These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27282303)

  • 1. Neurological Involvement in the Course of Scleromyxedema: A Case Report.
    Spagnolo F; Nozzoli C; Rini A; La Spada S; De Marco V; Passarella B
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):e148-50. PubMed ID: 27282303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
    Rey JB; Luria RB
    J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermato-neuro syndrome during scleromyxedema: efficacy of plasmapheresis and intravenous immunoglobulin].
    Charles S; Hainaut E; Cante V; Valette C; Levillain P; Guillet G
    Ann Dermatol Venereol; 2014; 141(8-9):523-7. PubMed ID: 25209816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleromyxedema: clinical diagnosis and autopsy findings.
    Sala AC; Cunha PR; Pinto CA; Alves CA; Paiva IB; Araujo AP
    An Bras Dermatol; 2016; 91(5 suppl 1):48-50. PubMed ID: 28300892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Encephalitic Syndrome Induced by Scleromyxedema.
    Magira EE; Malouchou A; Karathanasi V; Mavropoulou N; Siempos II; Vourlakou C; Sykaras A; Anastasiadis G
    Am J Med Sci; 2020 Aug; 360(2):192-195. PubMed ID: 32540147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy and scleromyxedema.
    Soulages A; Tang HM; Pham-Ledard A; Négrier-Leibreich ML; Cosnard A; Duval F; Solé G; Carla L; Le Masson G; Mathis S
    J Neurol; 2019 Aug; 266(8):2051-2059. PubMed ID: 31115676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].
    Bielsa I; Benvenutti F; Guinovart RM; Ferrándiz C
    Actas Dermosifiliogr; 2012 May; 103(4):317-20. PubMed ID: 21917233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature.
    Fleming KE; Virmani D; Sutton E; Langley R; Corbin J; Pasternak S; Walsh NM
    J Cutan Pathol; 2012 May; 39(5):508-17. PubMed ID: 22515222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual granulomatous variant of scleromyxedema.
    Stetsenko GY; Vary JC; Olerud JE; Argenyi ZB
    J Am Acad Dermatol; 2008 Aug; 59(2):346-9. PubMed ID: 18485525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide.
    Peter LM; Ammoury A; Chiavassa-Gandois H; Lamant L; Paul CF
    Clin Exp Dermatol; 2008 Aug; 33(5):606-10. PubMed ID: 18477005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
    Manousaridis I; Loeser C; Goerdt S; Hassel JC
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does dermatoneuro syndrome have a viral aetiology?
    Bhoyrul B; Mughal AA; Paulus J; Salamat A; Howarth S
    Clin Exp Dermatol; 2016 Jan; 41(1):53-6. PubMed ID: 26175017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.
    Rongioletti F; Rebora A
    J Am Acad Dermatol; 2001 Feb; 44(2):273-81. PubMed ID: 11174386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resident Rounds part III: scleromyxedema: a rare disorder associated with a monoclonal gammopathy.
    Mandell JA; Glick JB; Kaur RR
    J Drugs Dermatol; 2014 May; 13(5):619-20. PubMed ID: 24809891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermato-neuro syndrome associated with scleromyxedema.
    Karaman B; Guler A; Ertam I; Celebisoy N
    Indian J Dermatol Venereol Leprol; 2015; 81(5):519-21. PubMed ID: 26261151
    [No Abstract]   [Full Text] [Related]  

  • 16. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
    Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
    Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleromyxedema: An Atypical Case.
    Thomas E; George A; Deodhar D; John M
    Indian J Dermatol; 2015; 60(3):323. PubMed ID: 26120184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.
    Delyon J; Bézier M; Rybojad M; Brière J; Validire P; Bagot M; Janin A; Battistella M
    Virchows Arch; 2013 Jun; 462(6):679-83. PubMed ID: 23681113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case for diagnosis. Lichen myxedematosus.
    Rebellato PR; Carbonar MB; Tabuti NI; Rastelli GJ
    An Bras Dermatol; 2016; 91(6):842-843. PubMed ID: 28099617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized papular and sclerodermoid eruption: scleromyxedema.
    Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.